Total Payments
$28,941
2024 Payments
$989.07
Companies
5
Transactions
34
Payment Breakdown by Category
Research$20,292 (70.1%)
Travel$3,747 (12.9%)
Consulting$2,196 (7.6%)
Food & Beverage$1,581 (5.5%)
Other$1,125 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,292 | 2 | 70.1% |
| Travel and Lodging | $3,747 | 14 | 12.9% |
| Consulting Fee | $2,196 | 1 | 7.6% |
| Food and Beverage | $1,581 | 16 | 5.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,125 | 1 | 3.9% |
Payments by Type
Research
$20,292
2 transactions
General
$8,649
32 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $23,123 | 10 | $0 (2020) |
| Merck Sharp & Dohme LLC | $3,123 | 16 | $0 (2024) |
| Sanofi Pasteur Inc. | $2,531 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $100.01 | 1 | $0 (2018) |
| Lilly USA, LLC | $63.93 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $989.07 | 7 | Merck Sharp & Dohme LLC ($989.07) |
| 2023 | $1,009 | 8 | Merck Sharp & Dohme LLC ($1,009) |
| 2022 | $1,125 | 1 | Merck Sharp & Dohme LLC ($1,125) |
| 2020 | $3,886 | 2 | Eli Lilly and Company ($3,822) |
| 2019 | $16,470 | 1 | Eli Lilly and Company ($16,470) |
| 2018 | $2,631 | 7 | Sanofi Pasteur Inc. ($2,531) |
| 2017 | $2,831 | 8 | Eli Lilly and Company ($2,831) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $486.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $159.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $104.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $72.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $87.45 | General |
| 05/16/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $214.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $49.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $49.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $236.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $214.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $123.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $88.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/26/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $63.93 | General |
| 01/14/2020 | Eli Lilly and Company | — | — | In-kind items and services | $3,821.89 | Research |
| Study: A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES | ||||||
| 03/21/2019 | Eli Lilly and Company | — | — | In-kind items and services | $16,469.65 | Research |
| Study: A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES | ||||||
| 11/29/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $2,196.00 | General |
| 11/09/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $142.03 | General |
| 11/09/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $52.38 | General |
| 11/09/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $51.00 | General |
| 11/09/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $47.70 | General |
| 11/09/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $41.90 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES | Eli Lilly and Company | $20,292 | 2 |
About Dr. Carlos Sariol, MD
Dr. Carlos Sariol, MD is a Family Medicine healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083746135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Sariol, MD has received a total of $28,941 in payments from pharmaceutical and medical device companies, with $989.07 received in 2024. These payments were reported across 34 transactions from 5 companies. The most common payment nature is "" ($20,292).
Ad
Practice Information
- Specialty Family Medicine
- Location San Juan, PR
- Active Since 03/12/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083746135
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $2,531
- TALTZ (Drug) $1,769
- ZERBAXA (Drug) $1,125
- ENTRESTO (Drug) $100.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Juan
Mrs. Lizette Santiago, M.d, M.D
Family Medicine — Payments: $488,982
Family Medicine $488,982
Beigno Gonzalez
Family Medicine — Payments: $55,114
Family Medicine $55,114
Dr. Victor Villarreal, Md, MD
Family Medicine — Payments: $16,256
Family Medicine $16,256
Jose Mulero Fernandez, Md, MD
Family Medicine — Payments: $10,188
Family Medicine $10,188
Dr. Carlos Vera Muniz, Md, MD
Family Medicine — Payments: $9,414
Family Medicine $9,414
Yanira Fernandez Esteves, Md, MD
Family Medicine — Payments: $9,407
Family Medicine $9,407